论文部分内容阅读
目的构建上市中药企业竞争力评价指标体系,为评价我国上市中药企业竞争力提供有效的技术和手段。方法通过文献研究初步得到指标库,然后采用德尔菲法进行咨询,请20名相关领域资深专家依据各指标重要性打分,筛选上市中药企业竞争力评价指标体系维度及指标池,经过2轮问卷咨询,最终形成指标体系。结果第1、2轮问卷咨询的专家积极系数分别为95%、100%,专家权威程度为0.713 2,专家协调系数分别为0.659、0.639,指标体系最终包含5个1级指标、26个2级指标。结论本次德尔菲法专家积极系数及权威程度均较高,第2轮咨询专家的意见已趋于一致,形成的上市中药企业竞争力评价指标体系结果可信。
Objective To establish the evaluation index system of listed Chinese medicine enterprises competitiveness and provide effective technologies and means for evaluating the competitiveness of listed Chinese medicine enterprises in China. Methods The index library was obtained through literature review, and then Delphi method was used for consultation. 20 senior experts in relevant fields were scored according to the importance of each index to screen the index system dimension and index pool of competitiveness of listed Chinese medicine enterprises. After two rounds of questionnaires , Eventually forming an indicator system. Results The first and second questionnaire consultation experts’ positive coefficients were 95% and 100% respectively, the degree of expert authority was 0.713 2, the expert coordination coefficient was 0.659 and 0.639 respectively, and the index system finally contained 5 first-level indicators and 26 second-level indicators index. Conclusion This Delphi method has a positive coefficient and a high degree of authority. The opinions of the second round of consultants have become more consistent. The evaluation index system of the competitiveness of listed Chinese medicine enterprises formed is credible.